• FDA expands label of first universal Hepatitis C drug pharmaceutical-technology
    May 05, 2019
    The US Food and Drug Administration (FDA) has approved AbbVie’s Mavyret (glecaprevir and pibrentasvir), the first drug to treat all six genotypes of Hepatitis C virus (HCV), for children with the condition aged between 12 and 17.
PharmaSources Customer Service